Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

chemokine modulation therapy

Therapy used to modulate the activity of chemokine receptors or their ligands, potentially modifying immune response and tumor-related processes, including tumor cell growth, angiogenesis, and metastasis.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	chemokine targeted therapy
US brand name:	Optiray

chemokine modulation therapy

Search NCI's Drug Dictionary